|
AVL9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.02900000001449E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.753400E-04 |
| Normal-vs-Stage2 |
3.577600E-02 |
| Normal-vs-Stage3 |
3.58280000000155E-05 |
| Normal-vs-Stage4 |
2.741400E-03 |
| Stage1-vs-Stage2 |
9.626200E-01 |
| Stage1-vs-Stage3 |
9.014200E-02 |
| Stage1-vs-Stage4 |
3.603000E-01 |
| Stage2-vs-Stage3 |
2.787200E-01 |
| Stage2-vs-Stage4 |
5.241800E-01 |
| Stage3-vs-Stage4 |
6.903800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.35889999999905E-06 |
| Normal-vs-AfricanAmerican |
3.55630000004048E-06 |
| Normal-vs-Asian |
3.870000E-01 |
| Caucasian-vs-AfricanAmerican |
1.132780E-01 |
| Caucasian-vs-Asian |
2.036600E-01 |
| AfricanAmerican-vs-Asian |
1.412620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.87785999999912E-05 |
| Normal-vs-Female |
1.184660E-04 |
| Male-vs-Female |
9.992800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.662100E-02 |
| Normal-vs-Age(41-60Yrs) |
8.05280000000241E-05 |
| Normal-vs-Age(61-80Yrs) |
1.247750E-04 |
| Normal-vs-Age(81-100Yrs) |
1.80806999999783E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.564000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.647600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.972200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.879800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.774020E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.918400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.279600E-01 |
| Normal-vs-Grade 2 |
4.16589999999717E-05 |
| Normal-vs-Grade 3 |
2.34599999999752E-05 |
| Normal-vs-Grade 4 |
8.359500E-03 |
| Grade 1-vs-Grade 2 |
3.790800E-01 |
| Grade 1-vs-Grade 3 |
3.504000E-01 |
| Grade 1-vs-Grade 4 |
4.348000E-01 |
| Grade 2-vs-Grade 3 |
6.371000E-01 |
| Grade 2-vs-Grade 4 |
6.481800E-01 |
| Grade 3-vs-Grade 4 |
8.498400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.25750000000847E-05 |
| Normal-vs-ccB subtype |
5.308200E-02 |
| ccA subtype-vs-ccB subtype |
1.702220E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.964500E-04 |
| Normal-vs-N1 |
9.521000E-01 |
| N0-vs-N1 |
4.746000E-01 |
|
|
